In the BioHarmony Drug Report Database

"Preview" Icon

Inamrinone

Inocor (inamrinone) is a small molecule pharmaceutical. Inamrinone was first approved as Inocor on 1984-07-31. It is used to treat cardiogenic shock, dilated cardiomyopathy, heart failure, and low cardiac output in the USA. The pharmaceutical is active against cGMP-inhibited 3′,5′-cyclic phosphodiesterase A and cGMP-inhibited 3′,5′-cyclic phosphodiesterase B.

 

Trade Name

 

Inocor
 

Common Name

 

inamrinone
 

ChEMBL ID

 

CHEMBL12856
 

Indication

 

cardiogenic shock, dilated cardiomyopathy, heart failure, low cardiac output
 

Drug Class

 

Cardiotonics (amrinone type)

Image (chem structure or protein)

Inamrinone structure rendering